119 related articles for article (PubMed ID: 27599804)
21. A Study of Optimal Screening for Latent Tuberculosis in Patients with Inflammatory Bowel Disease.
Al-Taweel T; Strohl M; Pai M; Martel M; Bessissow T; Bitton A; Seidman E; Afif W
Dig Dis Sci; 2018 Oct; 63(10):2695-2702. PubMed ID: 29968143
[TBL] [Abstract][Full Text] [Related]
22. QuantiFERON-TB Gold In-Tube Test in the Diagnosis of Latent Tuberculosis Infection in Arthritis Patients Treated with Tumor Necrosis Factor Antagonists.
Baričević D; Popović Grle S; Morović Vergles J; Čuković Čavka S; Jakopović M; Redžepi G; Boras Z; Baričević M; Samaržija M
Acta Clin Croat; 2017 Jun; 56(2):203-209. PubMed ID: 29485786
[TBL] [Abstract][Full Text] [Related]
23. Tuberculosis in pediatric patients treated with anti-TNFα drugs: a cohort study.
Calzada-Hernández J; Anton-López J; Bou-Torrent R; Iglesias-Jiménez E; Ricart-Campos S; Martín de Carpi J; ; Torrente-Segarra V; Sánchez-Manubens J; Giménez-Roca C; Rozas-Quesada L; Juncosa-Morros MT; Fortuny C; Noguera-Julian A
Pediatr Rheumatol Online J; 2015 Dec; 13():54. PubMed ID: 26635208
[TBL] [Abstract][Full Text] [Related]
24. Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA-based protocol in UK subjects with inflammatory bowel disease suitable for anti-TNFα therapy.
Greveson K; Goodhand J; Capocci S; Woodward S; Murray C; Cropley I; Hamilton M; Lipman M
J Crohns Colitis; 2013 Jun; 7(5):412-8. PubMed ID: 23009739
[TBL] [Abstract][Full Text] [Related]
25. Use of Quantiferon-TB-Gold in Tube(®) test for detecting latent tuberculosis in patients considered as candidates for anti-TNF therapy in routine clinical practice.
García-Gasalla M; Fernández-Baca V; Juan-Mas A; Payeras-Cifre A; Cifuentes-Luna C; Taberner-Ferrer R; Riera-Oliver J; Ros-Villamajó I; Navarro-Fernández V; Morey Torrandell C; Gallegos-Alvarez C; Mir-Villadrich I
Enferm Infecc Microbiol Clin; 2013 Feb; 31(2):76-81. PubMed ID: 22902246
[TBL] [Abstract][Full Text] [Related]
26. Low Indeterminate Rates Associated With Use of the QuantiFERON-TB Gold In-Tube Test in Children With Inflammatory Bowel Disease on Long-term Infliximab.
Vortia E; Uko VE; Yen-Lieberman B; Frawley J; Worley SE; Danziger-Isakov L; Kaplan B; Mahajan L
Inflamm Bowel Dis; 2018 Mar; 24(4):877-882. PubMed ID: 29562270
[TBL] [Abstract][Full Text] [Related]
27. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES
PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688
[TBL] [Abstract][Full Text] [Related]
28. Pre-employment screening of latent tuberculosis infection among healthcare workers using tuberculin skin test and QuantiFERON-TB Gold test at a tertiary care hospital in Saudi Arabia.
El-Helaly M; Khan W; El-Saed A; Balkhy HH
J Infect Public Health; 2014; 7(6):481-8. PubMed ID: 25194817
[TBL] [Abstract][Full Text] [Related]
29. Detection of latent tuberculosis infection among migrant farmworkers along the US-Mexico border.
Oren E; Fiero MH; Barrett E; Anderson B; Nuῆez M; Gonzalez-Salazar F
BMC Infect Dis; 2016 Nov; 16(1):630. PubMed ID: 27809805
[TBL] [Abstract][Full Text] [Related]
30. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
[TBL] [Abstract][Full Text] [Related]
31. Screening for latent tuberculosis infection in patients with inflammatory bowel disease: Can interferon-gamma release assays replace the tuberculin skin test?
Cabriada JL; Ruiz-Zorrilla R; Barrio J; Atienza R; Huerta A; Rodríguez-Lago I; Bernal A; Herrero C
Turk J Gastroenterol; 2018 May; 29(3):292-298. PubMed ID: 29755013
[TBL] [Abstract][Full Text] [Related]
32. Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases.
Hatzara C; Hadziyannis E; Kandili A; Koutsianas C; Makris A; Georgiopoulos G; Vassilopoulos D
Ann Rheum Dis; 2015 Oct; 74(10):1848-53. PubMed ID: 24854354
[TBL] [Abstract][Full Text] [Related]
33. Prevention of anti-tumor necrosis factor-associated tuberculosis: a 10-year longitudinal cohort study.
Muñoz L; Casas S; Juanola X; Bordas X; Martinez C; Santin M;
Clin Infect Dis; 2015 Feb; 60(3):349-56. PubMed ID: 25313252
[TBL] [Abstract][Full Text] [Related]
34. Corticosteroids and immunosuppressive therapy influence the result of QuantiFERON TB Gold testing in inflammatory bowel disease patients.
Helwig U; Müller M; Hedderich J; Schreiber S
J Crohns Colitis; 2012 May; 6(4):419-24. PubMed ID: 22398067
[TBL] [Abstract][Full Text] [Related]
35. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H
Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
[TBL] [Abstract][Full Text] [Related]
37. Mycobacterium Tuberculosis Infection, Immigration Status, and Diagnostic Discordance: A Comparison of Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test Among Immigrants to the U.S.
Wilson FA; Miller TL; Stimpson JP
Public Health Rep; 2016; 131(2):303-10. PubMed ID: 26957665
[TBL] [Abstract][Full Text] [Related]
38. Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy.
Mariette X; Baron G; Tubach F; Lioté F; Combe B; Miceli-Richard C; Flipo RM; Goupille P; Allez M; Salmon D; Emilie D; Carcelain G; Ravaud P
Ann Rheum Dis; 2012 Nov; 71(11):1783-90. PubMed ID: 22258485
[TBL] [Abstract][Full Text] [Related]
39. Factors impacting the results of interferon-γ release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases.
Papay P; Eser A; Winkler S; Frantal S; Primas C; Miehsler W; Novacek G; Vogelsang H; Dejaco C; Reinisch W
Inflamm Bowel Dis; 2011 Jan; 17(1):84-90. PubMed ID: 20722065
[TBL] [Abstract][Full Text] [Related]
40. Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana.
Mensah GI; Sowah SA; Yeboah NY; Addo KK; Jackson-Sillah D
Int J Mycobacteriol; 2017; 6(1):27-33. PubMed ID: 28317801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
